{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:12:54Z","timestamp":1791295974492,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.biocel.2008.01.022","type":"journal-article","created":{"date-parts":[[2008,2,2]],"date-time":"2008-02-02T07:50:36Z","timestamp":1201938636000},"page":"1443-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["The endothelin axis in cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"Anna","family":"Bagnato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rosan\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2008.01.022_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1593\/neo.06388","article-title":"Endothelin receptor A blockade enhances taxane effects in prostate cancer","volume":"8","author":"Akhavan","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.biocel.2008.01.022_bib2","first-page":"6381","article-title":"Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade","volume":"62","author":"Bagnato","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-03-2344","article-title":"Endothelin B receptor blockade inhibits dynamic of cell interactions and communications in melanoma cell progression","volume":"64","author":"Bagnato","year":"2004","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1677\/erc.1.01077","article-title":"Emerging role of the endothelin axis in ovarian tumor progression","volume":"12","author":"Bagnato","year":"2005","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.biocel.2008.01.022_bib5","doi-asserted-by":"crossref","first-page":"6296s","DOI":"10.1158\/1078-0432.CCR-06-0929","article-title":"Targeting bone metastasis in prostate cancer with endothelin receptor antagonists","volume":"12","author":"Carducci","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1526-4637.2001.002001024.x","article-title":"Endothelin-1 and metastatic cancer pain","volume":"2","author":"Davar","year":"2001","journal-title":"Pain Medicine"},{"key":"10.1016\/j.biocel.2008.01.022_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0026-895X(24)12115-3","article-title":"Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: Requirement for Akt activation","volume":"61","author":"Del Bufalo","year":"2002","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.biocel.2008.01.022_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/labinvest.3780178","article-title":"The endothelin system in human glioblastoma","volume":"80","author":"Egidy","year":"2000","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.biocel.2008.01.022_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/ERC-07-0057","article-title":"Endothelins and hypoxia-inducible factor in cancer","volume":"14","author":"Grimshaw","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.biocel.2008.01.022_bib10","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib11","first-page":"133","article-title":"The role of the endothelin axis and microvessel density in bladder cancer\u2013correlation with tumor angiogenesis and clinical prognosis","volume":"18","author":"Herrmann","year":"2007","journal-title":"Oncology Reproduction"},{"key":"10.1016\/j.biocel.2008.01.022_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1359-6349(07)70096-4","article-title":"ZD4054, a potent, specific endothelin A receptor antagonist, improves overall survival in pain-free or mildly symptomatic patients with hormone-resistant prostate cancer (HRPC) and bone metastases","volume":"5","author":"James","year":"2007","journal-title":"European Journal of Cancer (Suppl.)"},{"key":"10.1016\/j.biocel.2008.01.022_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10637-006-9014-7","article-title":"A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma","volume":"25","author":"Kefford","year":"2007","journal-title":"Investigation New Drugs"},{"key":"10.1016\/j.biocel.2008.01.022_bib14","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/cncr.21790","article-title":"Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma","volume":"106","author":"Mai","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.biocel.2008.01.022_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-200000002-00002","article-title":"The endothelin family: An overview","volume":"35","author":"Masaki","year":"2000","journal-title":"Journal of Cardiovascular Pharmacolology"},{"key":"10.1016\/j.biocel.2008.01.022_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc990","article-title":"The endothelin axis: Emerging role in cancer","volume":"3","author":"Nelson","year":"2003","journal-title":"Nature Review Cancer"},{"key":"10.1016\/j.biocel.2008.01.022_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/sj.bjc.6600810","article-title":"Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells","volume":"88","author":"Peduto Eberl","year":"2003","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.biocel.2008.01.022_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.canlet.2006.02.007","article-title":"Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor","volume":"246","author":"Pflug","year":"2007","journal-title":"Cancer Letter"},{"key":"10.1016\/j.biocel.2008.01.022_bib19","first-page":"2447","article-title":"Therapeutic targeting of the endothelin A receptor in human ovarian carcinoma","volume":"63","author":"Rosan\u00f2","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0002-9440(10)63702-9","article-title":"Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo","volume":"163","author":"Rosan\u00f2","year":"2003","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.biocel.2008.01.022_bib21","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1158\/0008-5472.CAN-05-2123","article-title":"Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells","volume":"65","author":"Rosan\u00f2","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib22","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1158\/0008-5472.CAN-07-0883","article-title":"Combined targeting of endothelin A receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity","volume":"67","author":"Rosan\u00f2","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib23","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcp.21246","article-title":"Mitogenic signaling pathways induced by G protein-coupled receptors","volume":"213","author":"Rozengurt","year":"2007","journal-title":"Journal of Cell Physiology"},{"key":"10.1016\/j.biocel.2008.01.022_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157016107781024082","article-title":"The endothelin axis: A novel target for pharmacotherapy of female malignancies","volume":"5","author":"Smollich","year":"2007","journal-title":"Current Vascular Pharmacology"},{"key":"10.1016\/j.biocel.2008.01.022_bib25","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1158\/0008-5472.CAN-06-2606","article-title":"Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells","volume":"67","author":"Spinella","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.biocel.2008.01.022_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.105.019620","article-title":"Positive inter-regulation between beta-catenin\/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells","volume":"69","author":"Sun","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.biocel.2008.01.022_bib27","first-page":"5310","article-title":"Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells","volume":"60","author":"Vacca","year":"2000","journal-title":"Cancer Research"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272508000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:28:40Z","timestamp":1761200920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272508000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1357272508000447"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2008.01.022","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endothelin axis in cancer","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2008.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}